Aridis Pharmaceuticals Aridis Pharmaceuticals Announces Pricing of Initial Public Offering Mon, 13 Aug 2018 19:31:00 -0400 Aridis Pharmaceuticals Launches Proposed Initial Public Offering Mon, 06 Aug 2018 09:00:00 -0400 Aridis Pharmaceuticals, Inc. Appoints Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer, and Mitchell H. Rosner, Ph.D. as Vice President of Quality Mon, 05 Mar 2018 03:30:00 -0500 Aridis Pharmaceuticals Forms Subsidiary to Develop and Market its Monoclonal Antibody Therapies in China Jointly Owned with Leading Chinese Pharmaceutical Company Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Tue, 27 Feb 2018 03:30:00 -0500 Aridis Pharmaceuticals, Inc. Appoints Alan H. Cohen, MD, as Senior Vice President of Clinical & Medical Affairs Mon, 07 Aug 2017 07:00:00 -0400